MX7309E - Metodo mejorado para la purificacion del factor antihemofilico humano - Google Patents

Metodo mejorado para la purificacion del factor antihemofilico humano

Info

Publication number
MX7309E
MX7309E MX8310732U MX1073283U MX7309E MX 7309 E MX7309 E MX 7309E MX 8310732 U MX8310732 U MX 8310732U MX 1073283 U MX1073283 U MX 1073283U MX 7309 E MX7309 E MX 7309E
Authority
MX
Mexico
Prior art keywords
purification
improved method
antihemophilic factor
human antihemophilic
human
Prior art date
Application number
MX8310732U
Other languages
English (en)
Inventor
Stephen I Chavin
Philip J Fay
Original Assignee
Miles Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Lab filed Critical Miles Lab
Publication of MX7309E publication Critical patent/MX7309E/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX8310732U 1982-08-05 1983-08-04 Metodo mejorado para la purificacion del factor antihemofilico humano MX7309E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/405,456 US4495175A (en) 1982-08-05 1982-08-05 Preparation of highly purified human antihemophilic factor

Publications (1)

Publication Number Publication Date
MX7309E true MX7309E (es) 1988-05-10

Family

ID=23603775

Family Applications (1)

Application Number Title Priority Date Filing Date
MX8310732U MX7309E (es) 1982-08-05 1983-08-04 Metodo mejorado para la purificacion del factor antihemofilico humano

Country Status (8)

Country Link
US (1) US4495175A (es)
EP (1) EP0104356B1 (es)
JP (1) JPS5944322A (es)
AU (1) AU567683B2 (es)
CA (1) CA1213214A (es)
DE (1) DE3369143D1 (es)
ES (1) ES524768A0 (es)
MX (1) MX7309E (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614795A (en) * 1982-08-05 1986-09-30 University Of Rochester Deglycosylated Human Factor VIII:C
EP0148843B2 (en) * 1983-03-21 1994-05-04 Novo Nordisk A/S A concentrate of the antihemophilic factor viii and a process for producing it
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
JPS61280866A (ja) * 1985-06-07 1986-12-11 アルフア・セラピユ−テイツク・コ−ポレイシヨン 人血液凝固第８因子の分離方法
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
ATE112287T1 (de) * 1987-12-21 1994-10-15 Miles Inc Faktor viii- gelfiltration.
US5177191A (en) * 1987-12-21 1993-01-05 Miles, Inc. Gel filtration of factor VIII
WO1989009784A1 (en) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production of heat-stable factor viii concentrate
DE3878245D1 (de) 1988-11-05 1993-03-18 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
DE3926034C3 (de) * 1989-08-07 1996-11-21 Behringwerke Ag Verfahren zur Herstellung eines stabilen Faktors VIII
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
DK162233C (da) * 1989-11-09 1992-03-16 Novo Nordisk As Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
US5516509A (en) * 1993-03-31 1996-05-14 International Beauty Design, Inc. Quick-drying nail coating for use over nail polish
US5407666A (en) * 1993-04-05 1995-04-18 International Beauty Design, Inc. Removable, hard, durable, nail coating
SE504074C2 (sv) * 1993-07-05 1996-11-04 Pharmacia Ab Proteinberedning för subkutan, intramuskulär eller intradermal administrering
GB9501040D0 (en) * 1995-01-19 1995-03-08 Quadrant Holdings Cambridge Dried composition
US7244824B2 (en) * 1995-01-19 2007-07-17 Quadrant Drug Delivery Limited Dried blood factor composition comprising trehalose
US7253262B2 (en) * 1995-01-19 2007-08-07 Quandrant Drug Delivery Limited Dried blood factor composition comprising trehalose
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US6077940A (en) * 1997-12-24 2000-06-20 Genentech, Inc. Free solution ligand interaction molecular separation method
CA2342606A1 (en) 1998-10-07 2000-04-13 Sigma-Aldrich Co. Thromboplastin reagents and methods for preparing and using such reagents
EP1154796B1 (en) * 1999-02-22 2007-06-20 University of Connecticut Novel albumin-free factor viii formulations
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188318A (en) * 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
CA1178887A (en) * 1981-10-01 1984-12-04 Gail A. Rock Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
AU555305B2 (en) * 1982-09-29 1986-09-18 Bayer Corporation Antihemophilic factor concentrate

Also Published As

Publication number Publication date
CA1213214A (en) 1986-10-28
JPS5944322A (ja) 1984-03-12
ES8501979A1 (es) 1984-12-16
US4495175A (en) 1985-01-22
ES524768A0 (es) 1984-12-16
AU1747283A (en) 1984-02-09
EP0104356A1 (en) 1984-04-04
AU567683B2 (en) 1987-12-03
EP0104356B1 (en) 1987-01-14
DE3369143D1 (en) 1987-02-19

Similar Documents

Publication Publication Date Title
MX7309E (es) Metodo mejorado para la purificacion del factor antihemofilico humano
ES542296A0 (es) Metodo para la preparacion del factor viii humano funcional
MX162188A (es) Procedimiento para la produccion de las n-arilsulfonil-n'-pirimidinil-ureas
AR231233A1 (es) Procedimiento para la produccion de fibrinogeno
IT8249249A0 (it) Procedimento per la fabbricazione di pannolini elasticizzati
ES536770A0 (es) Procedimiento para la obtencion del factor 2 de la teicomicina a2
ES532452A0 (es) Procedimiento para la purificacion de aguas residuales
ES535509A0 (es) Procedimiento para purificar interferon de humano
IT1194181B (it) Procedimento migliorato per la purificazione della tilosina
IT8348576A0 (it) Procedimento per la purificazione del fenolo
MX5197E (es) Metodo para la purificacion del factor antihemofilico
ES551763A0 (es) Procedimiento para la depuracion de aguas residuales
IT8421191A1 (it) Metodo per la purificazione del 4-fluorofenolo
ES544185A0 (es) Procedimiento para la purificacion del mercaptobenzotiazol
IT1163500B (it) Procedimento per la preparazione del meta-clorobenzotrifluoruro
MX165225B (es) Procedimiento para la producccion de un concentrado de factor antihemofilico
IT1203646B (it) Procedimento per la preparazione di cloroacetanilidi sostituite
AR240908A1 (es) Procedimiento para la fabricacion de 2-halogeno- resorcinol
MX6429E (es) Procedimiento para la purificacion de nicotinamida
IT8324025A1 (it) Procedimento per la purificazione di 2,6-xilenolo
IT8347756A0 (it) Procedimento per la purificazione di acetone
IT1164613B (it) Procedimento per la produzione di ditiazol-disolfuri
TR20950A (tr) Ortopedik tedavi yatagi
ES529988A0 (es) Procedimiento para la curticion de pieles
ES276853Y (es) Dispositivo perfeccionado para la practica del hidro-masaje